Partnership Extends Expertise in Pre-Clinical Imaging

MicroMatrices, a service provider specialised in high resolution cell type-specific analysis to characterise toxicological responses in different cell types in tissue, has formed a preferred partnership agreement with Advanced Cell Diagnostics (ACD), a leader in the field of molecular pathology and developer of cell and tissue-based analysis tools.

MicroMatrices solves molecular toxicological problems using visualisation and localisation technologies, adding resolving power to standard methodologies and has a team of a highly skilled scientists networked to facilities of excellence across the United Kingdom.

Dr Simon Plummer, Managing Director of MicroMatrices commented; "The power and versatility of RNAscope has been an invaluable tool to enable us to solve mode of action/efficacy/toxicity challenges for our clients in the pharmaceutical, agrochemical, and chemical industries. We are delighted to be partnering with ACD to promote the wider application of RNAscope technology in preclinical safety/drug development problem solving for our collaborators".

 “ACD has established high quality performance standards through RNAscope products and services and MicroMatrices is known for quality, service and expertise in the drug development community," said Dr Steve Chen, Chief Operating Officer of ACD.  "As ACD's install base is growing very rapidly in Europe, they are an ideal partner not only to extend our reach but also to solidify our commitment in service quality.”